1. Home
  2. KALA vs FPAY Comparison

KALA vs FPAY Comparison

Compare KALA & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • FPAY
  • Stock Information
  • Founded
  • KALA 2009
  • FPAY 2003
  • Country
  • KALA United States
  • FPAY United States
  • Employees
  • KALA N/A
  • FPAY N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • KALA Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • KALA 26.2M
  • FPAY 27.2M
  • IPO Year
  • KALA 2017
  • FPAY N/A
  • Fundamental
  • Price
  • KALA $7.14
  • FPAY $1.04
  • Analyst Decision
  • KALA Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • KALA 3
  • FPAY 2
  • Target Price
  • KALA $14.00
  • FPAY $3.25
  • AVG Volume (30 Days)
  • KALA 198.2K
  • FPAY 96.0K
  • Earning Date
  • KALA 08-05-2025
  • FPAY 08-05-2025
  • Dividend Yield
  • KALA N/A
  • FPAY N/A
  • EPS Growth
  • KALA N/A
  • FPAY N/A
  • EPS
  • KALA N/A
  • FPAY N/A
  • Revenue
  • KALA N/A
  • FPAY $139,800,732.00
  • Revenue This Year
  • KALA N/A
  • FPAY $16.58
  • Revenue Next Year
  • KALA N/A
  • FPAY N/A
  • P/E Ratio
  • KALA N/A
  • FPAY N/A
  • Revenue Growth
  • KALA N/A
  • FPAY 19.51
  • 52 Week Low
  • KALA $2.92
  • FPAY $0.84
  • 52 Week High
  • KALA $11.20
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • KALA 59.52
  • FPAY 36.61
  • Support Level
  • KALA $5.35
  • FPAY $0.84
  • Resistance Level
  • KALA $8.49
  • FPAY $1.37
  • Average True Range (ATR)
  • KALA 0.81
  • FPAY 0.10
  • MACD
  • KALA 0.17
  • FPAY -0.00
  • Stochastic Oscillator
  • KALA 57.01
  • FPAY 9.30

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: